Show simple item record

dc.contributor.authorRooney, Gemma E.
dc.contributor.authorMcMahon, Siobhan
dc.contributor.authorRitter, Thomas
dc.contributor.authorGarcia, Yolanda
dc.contributor.authorMoran, Cathal
dc.contributor.authorMadigan, Nicholas N.
dc.identifier.citationRooney, GE,McMahon, SS,Ritter, T,Garcia, Y,Moran, C,Madigan, NN,Flugel, A,Dockery, P,O'Brien, T,Howard, L,Windebank, AJ,Barry, FP (2009) 'Neurotrophic Factor-Expressing Mesenchymal Stem Cells Survive Transplantation into the Contused Spinal Cord Without Differentiating into Neural Cells'. Tissue Engineering Part A, 15 :3049-3059.en_US
dc.descriptionJournal articleen_US
dc.description.abstractThe aim of this study was to assess the feasibility of transplanting mesenchymal stem cells (MSCs), genetically modified to express glial-derived neurotrophic factor (GDNF), to the contused rat spinal cord, and to subsequently assess their neural differentiation potential. MSCs expressing green fluorescent protein were transduced with a retroviral vector to express the neurotrophin GDNF. The transduction protocol was optimized by using green fluorescent protein-expressing retroviral constructs; approximately 90% of MSCs were transduced successfully after G418 selection. GDNF-transduced MSCs expressed the transgene and secreted growth factor into the media (similar to 12 ng/500,000 cells secreted into the supernatant 2 weeks after transduction). Injuries were established using an impactor device, which applied a given, reproducible force to the exposed spinal cord. GDNF-expressing MSCs were transplanted rostral and caudal to the site of injury. Spinal cord sections were analyzed 2 and 6 weeks after transplantation. We demonstrate that GDNF-transduced MSCs engraft, survive, and express the therapeutic gene up to 6 weeks posttransplantation, while maintaining an undifferentiated phenotype. In conclusion, transplanted MSCs have limited capacity for the replacement of neural cells lost as a result of a spinal cord trauma. However, they provide excellent opportunities for local delivery of neurotrophic factors into the injured tissue. This study underlines the therapeutic benefits associated with cell transplantation and provides a good example of the use of MSCs for gene delivery.en_US
dc.publisherMary Ann Lieberten_US
dc.relation.ispartofTissue Engineering Part Aen
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Ireland
dc.subjectMarrow stromal cellsen_US
dc.subjectNerve growth factoren_US
dc.subjectBone marrowen_US
dc.subjectIn vitroen_US
dc.subjectAxonal growthen_US
dc.subjectAdult raten_US
dc.titleNeurotrophic Factor-Expressing Mesenchymal Stem Cells Survive Transplantation into the Contused Spinal Cord Without Differentiating into Neural Cellsen_US
dc.identifier.doiDOI 10.1089/ten.tea.2009.0045
dc.local.contactSiobhan Mcmahon, Department Of Anatomy, Nui, Galway. 2838 Email:

Files in this item


This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Ireland
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Ireland